GLUTARIC ACIDEMIA IIA
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.400 |
None |
1.000 |
1 |
3
|
2016 |
2016 |
Hepatic periportal necrosis
|
disease |
|
Disease or Syndrome
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Glutaric Aciduria IIA
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
|
0 |
|
|
|
Glutaric Aciduria IIB
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
|
0 |
|
|
|
Glutaric Aciduria IIC
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
|
0 |
|
|
|
Electron transfer flavoprotein-ubiquinone oxidoreductase defect
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Glutaric acidemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Neutral Lipid Storage Disease with Myopathy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
12
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Ethylmalonic aciduria
|
phenotype |
|
Finding
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Unresectable Melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Trichilemmoma
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
4
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Opioid-Induced Constipation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glutaric aciduria
|
phenotype |
|
Disease or Syndrome
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Mucormycosis
|
disease |
Infections
|
Disease or Syndrome
|
9
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Zygomycosis
|
disease |
Infections
|
Disease or Syndrome
|
9
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Early Awakening
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Generalized aminoaciduria
|
phenotype |
|
Finding
|
11
|
|
0.100 |
None |
|
0 |
|
|
|
Ependymoma of brain
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Ventricular dilatation (disorder)
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Erythrocyte Mean Corpuscular Hemoglobin Test
|
phenotype |
|
Laboratory Procedure
|
13
|
|
0.300 |
limited |
1.000 |
1 |
|
2016 |
2016 |
Diverticular Bleeding
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Renal cortical cysts
|
phenotype |
|
Finding
|
14
|
1
|
0.100 |
None |
|
0 |
|
|
|
Non-small cell lung cancer stage III
|
disease |
|
Neoplastic Process
|
16
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Histiocytoid hemangioma
|
disease |
Neoplasms
|
Neoplastic Process
|
18
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Generalized Lipodystrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
18
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |